Alexei Gogolev
Stock Analyst at JP Morgan
(3.71)
# 589
Out of 5,182 analysts
102
Total ratings
55.41%
Success rate
6.85%
Average return
Main Sectors:
Stocks Rated by Alexei Gogolev
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VRSN VeriSign | Maintains: Neutral | $273 → $278 | $267.90 | +3.77% | 3 | Apr 24, 2026 | |
| PHR Phreesia | Downgrades: Neutral | $24 → $16 | $9.62 | +66.32% | 3 | Mar 31, 2026 | |
| WIX Wix.com | Downgrades: Underweight | $114 → $91 | $76.53 | +18.91% | 6 | Mar 27, 2026 | |
| BRZE Braze | Maintains: Overweight | $32 → $33 | $23.25 | +41.94% | 2 | Mar 25, 2026 | |
| HQY HealthEquity | Maintains: Overweight | $129 → $123 | $83.47 | +47.36% | 2 | Mar 18, 2026 | |
| VEEV Veeva Systems | Maintains: Overweight | $330 → $296 | $160.45 | +84.48% | 2 | Feb 20, 2026 | |
| DOCS Doximity | Maintains: Neutral | $40 → $33 | $24.66 | +33.82% | 3 | Feb 20, 2026 | |
| INTA Intapp | Maintains: Overweight | $70 → $58 | $22.14 | +161.97% | 4 | Feb 4, 2026 | |
| PTC PTC Inc. | Downgrades: Underweight | $205 → $162 | $136.41 | +18.76% | 2 | Feb 2, 2026 | |
| APPF AppFolio | Maintains: Overweight | $330 → $300 | $169.75 | +76.73% | 5 | Jan 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $46 → $48 | $29.47 | +62.88% | 5 | Dec 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $65 → $74 | $36.77 | +101.25% | 1 | Dec 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $28 → $26 | $24.13 | +7.75% | 6 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $56 → $51 | $32.83 | +55.35% | 3 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $222 → $200 | $84.36 | +137.08% | 7 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $86 → $94 | $68.63 | +36.97% | 3 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $87 → $101 | $36.24 | +178.70% | 6 | Jul 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $271 → $288 | $136.62 | +110.80% | 9 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $97 → $85 | $55.65 | +52.74% | 8 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $42 → $45 | $15.78 | +185.17% | 4 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $10 → $11 | $11.69 | -5.90% | 3 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $500 → $526 | $337.58 | +55.81% | 3 | Feb 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $36 → $32 | $5.65 | +466.37% | 2 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $27 → $28 | $7.97 | +251.32% | 2 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $247 → $249 | $116.31 | +114.08% | 4 | Mar 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $73 → $55 | $51.87 | +6.04% | 4 | Mar 11, 2020 |
VeriSign
Apr 24, 2026
Maintains: Neutral
Price Target: $273 → $278
Current: $267.90
Upside: +3.77%
Phreesia
Mar 31, 2026
Downgrades: Neutral
Price Target: $24 → $16
Current: $9.62
Upside: +66.32%
Wix.com
Mar 27, 2026
Downgrades: Underweight
Price Target: $114 → $91
Current: $76.53
Upside: +18.91%
Braze
Mar 25, 2026
Maintains: Overweight
Price Target: $32 → $33
Current: $23.25
Upside: +41.94%
HealthEquity
Mar 18, 2026
Maintains: Overweight
Price Target: $129 → $123
Current: $83.47
Upside: +47.36%
Veeva Systems
Feb 20, 2026
Maintains: Overweight
Price Target: $330 → $296
Current: $160.45
Upside: +84.48%
Doximity
Feb 20, 2026
Maintains: Neutral
Price Target: $40 → $33
Current: $24.66
Upside: +33.82%
Intapp
Feb 4, 2026
Maintains: Overweight
Price Target: $70 → $58
Current: $22.14
Upside: +161.97%
PTC Inc.
Feb 2, 2026
Downgrades: Underweight
Price Target: $205 → $162
Current: $136.41
Upside: +18.76%
AppFolio
Jan 30, 2026
Maintains: Overweight
Price Target: $330 → $300
Current: $169.75
Upside: +76.73%
Dec 5, 2025
Maintains: Neutral
Price Target: $46 → $48
Current: $29.47
Upside: +62.88%
Dec 5, 2025
Maintains: Overweight
Price Target: $65 → $74
Current: $36.77
Upside: +101.25%
Nov 6, 2025
Maintains: Overweight
Price Target: $28 → $26
Current: $24.13
Upside: +7.75%
Nov 6, 2025
Maintains: Neutral
Price Target: $56 → $51
Current: $32.83
Upside: +55.35%
Oct 31, 2025
Maintains: Overweight
Price Target: $222 → $200
Current: $84.36
Upside: +137.08%
Jul 24, 2025
Maintains: Neutral
Price Target: $86 → $94
Current: $68.63
Upside: +36.97%
Jul 23, 2025
Maintains: Overweight
Price Target: $87 → $101
Current: $36.24
Upside: +178.70%
Jun 25, 2025
Maintains: Overweight
Price Target: $271 → $288
Current: $136.62
Upside: +110.80%
Apr 9, 2025
Maintains: Overweight
Price Target: $97 → $85
Current: $55.65
Upside: +52.74%
Dec 9, 2024
Maintains: Overweight
Price Target: $42 → $45
Current: $15.78
Upside: +185.17%
Aug 7, 2024
Maintains: Underweight
Price Target: $10 → $11
Current: $11.69
Upside: -5.90%
Feb 15, 2024
Maintains: Overweight
Price Target: $500 → $526
Current: $337.58
Upside: +55.81%
Aug 9, 2023
Maintains: Underweight
Price Target: $36 → $32
Current: $5.65
Upside: +466.37%
Jul 31, 2023
Maintains: Outperform
Price Target: $27 → $28
Current: $7.97
Upside: +251.32%
Mar 11, 2020
Maintains: Overweight
Price Target: $247 → $249
Current: $116.31
Upside: +114.08%
Mar 11, 2020
Upgrades: Neutral
Price Target: $73 → $55
Current: $51.87
Upside: +6.04%